As previously announced, 2018-01-09 and 2018-01-30, SensoDetect has signed an agreement with its Bolivian distributor on the initiation of a study on a specialist hospital in Santa Cruz Central Bolivia. The study, which is part of the marketing campaign, will start in February/March this year and is based on the new BERA 3.0. The first
SensoDetect has decided to now completely discontinue the marketing of old BERA 2 when the new BERA 3.0 is soon launched. As part of this also closes the MDD registration of old BERA 2 and instead the new BERA will be certified according to the new standard. SensoDetect has decided, as part of the change
SensoDetect has signed a cooperation agreement with Innomedica from Finland regarding the identification of potential partners and distributors in Europe with a focus on Germany and the UK. Sensodetect have chosen to collaborate with Innomedica from Finland to strengthen the focus on the markets in Europe, mainly Germany and the UK Innomedica Ltd. (founded in
SensoDetect installation and training in Bolivia is planned together with the distributor in one of the hospitals in Santa Cruz. SensoDetect will during the end of February have a person in place to install a first prototype system of BERA 3.0. The Distributor will first be trained in the technology, so they can offer local
SensoDetect has now received data from a new group of obsessive-compulsive disorder (OCD) that will be evaluated to supplement BERA 3.0 with additional report if possible. SensoDetect BERA 3.0 will initially focus on ADHD according to previous plan and is supplemented with autism and schizophrenia. These tests will give the doctor a wider material to
SensoDetect has strengthened the development and analysis team with additional AI (Artificial Intelligence) and analysis expert. SensoDetect has a strong team working to transform the company from focusing on research and development to market and sales deliverables. Automation, infrastructure and efficiency in everything from routines, handling and analysis. The new BERA 3.0 will offer completely
SensoDetect and The Bolivian Distributor have signed a letter of agreement to conduct an initial study in a specialist hospital in central Bolivia. This study will start in February/march this year and will be based on the new BERA 3.0. The agreement is covering three steps that will evaluate and test the BERA 3.0 in
SensoDetect Bera V3.0 is undergoing a validation with the aim of being able to CE mark the new product soon. The product is improved on a number of points, including stability, size and ease of use. In the development work, we have, based on the proven basic design of the existing system, modernized and streamlined
SensoDetect has signed a LOI (letter Of Intent) with a South Korean distributor. The parties met for the first time this summer in connection with a major conference in the Copenhagen area and now, after a second meeting, the parties agreed on the bases for further cooperation as clarified in the LOI. The aim is
New video presentation published to strengthen work with marketing and sales. The video is part of a larger marketing package that has been developed in accordance with the strategy that the company presented with objectives to reach sales of about 20 million in 2020. The strategy’s focus is to launch BERA 3.0 in the spring